2nd UPDATE:Bristol-Myers 3Q Net Down On Generic CompetitionEasy Bourse (Communiqués de presse), France - 5 hours ago… Reyataz, an HIV treatment, generated sales of $233 million, up 32%. Sales of the Abilify antipsychotic rose 20% to $313 million. …
Read full story
Bristol-Myers Profit Falls as Plavix Copy Hurts Sales (Update5)Bloomberg - Oct 26, 2006… Sales of Baraclude, a hepatitis B treatment, tripled to $22 million. Schizophrenia treatment Abilify sales were up 20 percent, to $313 million.
Read full story
Bristol-Myers Squibb Q3 Profit Plummets On Reduction In Plavix …Trading Markets, CA - Oct 26, 2006… Globally, Erbitux sales rose 64% to $175 million from $107 million, while sales of antipsychotic Abilify advanced to $313 million from $260 million. …
Read full story
Generic Competition Plagues Bristol-MyersSmartmoney.com - Oct 26, 2006… Reyataz, an HIV treatment, generated sales of $233 million, up 32%. Sales of the Abilify antipsychotic rose 20% to $313 million. …
Read full story
Probe of Bristol-Myers widens, to include possible securities …Newark Star Ledger, USA - Oct 26, 2006… sales by Bristol-Myer's other leading products — cancer drug Erbitux, up 64 percent, AIDS treatment Reyataz, up 32 percent, antipsychotic agent Abilify, up 20 … Bristol-Myers Squibb Q3 Profit Plummets On Reduction In Plavix … Trading MarketsBristol-Myers Profit Falls as Plavix Copy Hurts Sales (Update5) BloombergGeneric Competition Plagues Bristol-Myers Smartmoney.comall 128 news articles
Read full story
Solvay and Wyeth: Potential Blockbuster Submitted for ApprovalInternational News Service, Australia - Oct 13, 2006… Bifeprunox will be the second partial dopamine agonist to reach the market, following the successful launch of Abilify by Bristol-Myers Squibb in 2002, and is …
Read full story
FDA Gives OK for Schizophrenia TreatmentKFMB, CA - Oct 24, 2006… Newer drugs such as Seroquel, Eli Lilly & Co.'s Zyprexa, Johnson & Johnson's Risperdal and Bristol-Myers Squibb Co.'s Abilify are intended to have fewer side …
Read full story
CNNMoney.comBristol-Myers Squibb Company Reports Financial Results for the …Yahoo! News (press release) - 11 hours ago… received approval from the FDA in September and the EMEA in October for ABILIFY® Injection, the first ready-to-use single-dose vial of an atypical … Bristol-Myers Squibb Q3 Profit Plummets On Reduction In Plavix … Trading MarketsGeneric Competition Plagues Bristol-Myers Smartmoney.comall 178 news articles
Read full story
FDA Approves AstraZeneca Depression DrugMSN Money - Oct 23, 2006… Newer drugs such as Seroquel, Eli Lilly & Co.'s Zyprexa, Johnson & Johnson's Risperdal and Bristol-Myers Squibb Co.'s Abilify are intended to have fewer side …
Read full story
FDA paves the way for AstraZeneca and depressive bipolar disorder …Earthtimes.org - Oct 23, 2006… There are a variety of drugs including Seroquel in the market: Eli Lilly & Co.'s Zyprexa, Johnson & Johnson's Risperdal and Bristol-Myers Squibb Co.'s Abilify. …
Read full story